Target intelligence / Profile preview

Spindlin family member 2A (SPIN2A)

Target
SPIN2A
Molecular classification
Spindlin family protein, Chromatin-associated protein, Histone modification reader (H3K4me3-binding activity), Nuclear protein
01

Overview

Spindlin family member 2A (SPIN2A) is a nuclear protein encoded on the X chromosome, part of the spindlin family which contains a characteristic repeat motif (Spin/Ssty repeat) implicated in chromatin interactions and cell cycle progression[1][2][3][7]. SPIN2A is notable for its ability to bind to the histone modification H3K4me3, functioning as a chromatin reader and potentially modulating transcriptional activity in relation to cell cycle control[3][7][10]. It has been associated with genetic disorders such as hypogonadotropic hypogonadism, but its broader roles in disease are still emerging. While it is a protein-coding gene with experimentally validated interactions, it is currently not known to have direct drug modulators. The potential functional impact of SPIN2A relates to early embryonic development, mitosis, and meiosis, akin to other spindlin family members[2][10]. There are no current clinical biomarkers or safety concerns documented for therapeutic use. SPIN2A’s principal molecular functions are cell cycle regulation and chromatin recognition, and it acts as a potential target for modulating transcriptional and epigenetic processes[1][3][7].

Other names
SPIN2ASPIN2DXF34
02

Mechanism of action

None established; drugs would likely act by modulating chromatin reader function or cell cycle regulation if developed

03

Biological functions

Regulation of cell cycle progressionChromatin binding and histone methylation reader activity (specifically H3K4me3)May influence gametogenesis, oogenesis, spermatogenesis (inferred from family)
04

Disease associations

Hypogonadotropic hypogonadism 12 with or without anosmiaOther roles in cell proliferation possible (based on general chromatin reader function and cell cycle regulation)
05

Safety considerations

None documented for interventions targeting SPIN2AAs a chromatin reader protein, manipulation could affect fundamental nuclear processes (cell cycle, gene expression), suggesting potential risk if targeted (inferred)
06

Interacting drugs

None directly listed or characterized in public databases or literature as of the current date
07

Biomarkers

None specifically established for patient selection or efficacy monitoringAlterations in H3K4me3 recognition or function might serve as a potential biomarker, but this is not documented for clinical use

Beyond the preview

Go deeper on Spindlin family member 2A (SPIN2A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Spindlin family member 2A (SPIN2A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call